GYRE THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DFAN14A
EFFECT
FWP
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001140361-26-010654 | Mar 23, 2026 | Mar 22, 2026 |
| 10-K | 10-K | 0001193125-26-106251 | Mar 13, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001140361-26-009115 | Mar 12, 2026 | Mar 10, 2026 |
| 8-K | 8-K | 0001193125-26-102700 | Mar 12, 2026 | — |
| 8-K | 8-K | 0001140361-26-007249 | Mar 2, 2026 | — |
| 4 | FORM 4 | 0001140361-26-000832 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | FORM 4 | 0001140361-26-000831 | Jan 9, 2026 | Jan 7, 2026 |
| 8-K | FORM 8-K | 0001140361-26-000253 | Jan 5, 2026 | — |
| 144 | — | 0001985496-25-000003 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-272383 | Nov 7, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-270524 | Nov 7, 2025 | — |
| 8-K | 8-K | 0001140361-25-034506 | Sep 10, 2025 | — |
| 4 | FORM 4 | 0001140361-25-032719 | Aug 26, 2025 | Aug 18, 2025 |
| 3 | FORM 3 | 0001140361-25-032710 | Aug 26, 2025 | Aug 18, 2025 |
| 8-K | 8-K | 0001140361-25-032295 | Aug 22, 2025 | Aug 18, 2025 |
| 10-Q | 10-Q | 0000950170-25-106644 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-106525 | Aug 11, 2025 | Aug 5, 2025 |
| 4 | FORM 4 | 0001140361-25-029693 | Aug 7, 2025 | Aug 5, 2025 |
| 4 | FORM 4 | 0001140361-25-021793 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001140361-25-021792 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001140361-25-021791 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001140361-25-021790 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001140361-25-021789 | Jun 6, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001140361-25-021612 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001140361-25-020754 | May 29, 2025 | May 27, 2025 |
| 4 | FORM 4 | 0001140361-25-020669 | May 28, 2025 | May 27, 2025 |
| 4 | FORM 4 | 0001140361-25-020474 | May 27, 2025 | May 22, 2025 |
| 8-K | 8-K | 0001140361-25-020353 | May 23, 2025 | May 22, 2025 |
| 424B5 | 424B5 | 0001140361-25-020349 | May 23, 2025 | — |
| 424B5 | 424B5 | 0001140361-25-020208 | May 22, 2025 | — |
| 8-K | 8-K | 0001140361-25-020157 | May 22, 2025 | — |
| 4 | FORM 4 | 0001140361-25-020156 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001140361-25-019893 | May 20, 2025 | May 16, 2025 |
| 4 | FORM 4 | 0001140361-25-019468 | May 16, 2025 | May 14, 2025 |
| 4 | FORM 4 | 0001140361-25-019053 | May 14, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001140361-25-018927 | May 14, 2025 | May 12, 2025 |
| 10-Q | 10-Q | 0000950170-25-068089 | May 9, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-067452 | May 9, 2025 | — |
| 8-K | 8-K | 0001140361-25-015880 | Apr 28, 2025 | — |
| 4 | FORM 4 | 0001140361-25-015712 | Apr 25, 2025 | Mar 24, 2025 |
| ARS | ARS | 0001140361-25-014874 | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001140361-25-014780 | Apr 21, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-014779 | Apr 21, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001140361-25-014601 | Apr 18, 2025 | Apr 16, 2025 |
| 4 | FORM 4 | 0001140361-25-010234 | Mar 25, 2025 | Mar 21, 2025 |
| 4 | FORM 4 | 0001140361-25-009877 | Mar 21, 2025 | Mar 19, 2025 |
| S-8 | S-8 | 0001140361-25-009676 | Mar 20, 2025 | — |
| 4 | FORM 4 | 0001140361-25-009424 | Mar 19, 2025 | Mar 17, 2025 |
| 10-K | 10-K | 0000950170-25-040279 | Mar 17, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-040232 | Mar 17, 2025 | — |